<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="173536">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00836862</url>
  </required_header>
  <id_info>
    <org_study_id>482-08-EP</org_study_id>
    <nct_id>NCT00836862</nct_id>
  </id_info>
  <brief_title>Arteriovenous Fistula Tissue Bank</brief_title>
  <official_title>Arteriovenous Fistula Tissue Bank</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nebraska</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nebraska</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project will bank sera, DNA and vascular specimens from patients undergoing
      arteriovenous fistula creation and revision
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2009</start_date>
  <primary_completion_date type="Anticipated">November 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Kidney Failure, Chronic</condition>
  <arm_group>
    <arm_group_label>Arteriovenous Fistula</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biologic specimens</intervention_name>
    <description>Banking of serum, DNA and tissue</description>
    <arm_group_label>Arteriovenous Fistula</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, Whole Blood, Tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be eligible if they are 19 years of age or greater and have placement of an
        arteriovenous fistula planned witin 30 days.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 19 years of age or greater

          -  Arteriovenous fistula placement for hemodialysis access scheduled within 30 days

        Exclusion Criteria:

          -  Incompetent to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Nebraska Medical Center/The Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>LuAnn Larson, RN, BSN</last_name>
      <phone>402-559-8555</phone>
      <email>llarson@unmc.edu</email>
    </contact>
    <investigator>
      <last_name>Troy J Plumb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2010</verification_date>
  <lastchanged_date>July 15, 2010</lastchanged_date>
  <firstreceived_date>February 3, 2009</firstreceived_date>
  <responsible_party>
    <name_title>Troy J. Plumb, MD</name_title>
    <organization>University of Nebraska Medical Center</organization>
  </responsible_party>
  <keyword>Hemodialysis</keyword>
  <keyword>Vascular access</keyword>
  <keyword>Arteriovenous fistula</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Arteriovenous Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
